China's Innovent Biologics saidon Monday its GLP-1 injection led to more weight loss and better control of blood sugar in ...
A boardroom shake-up at Novo Nordisk has handed unprecedented power to its top shareholder, the Novo Nordisk Foundation, ...
In the latest close session, Novo Nordisk (NVO) was down 1.59% at $52.05. The stock trailed the S&P 500, which registered a daily gain of 0.23%. On the other hand, the Dow registered a gain of 0.34%, ...
Novo Nordisk today announced plans to present 11 abstracts at the 76th Annual American Association for the Study of Liver ...
Some investors may welcome the Novo Nordisk Foundation’s sweeping moves to accelerate a strategy shift. Yet the speed and ...
Somehow, it’s becoming even harder to get a GLP-1.
Sure, Eli Lilly’s Tirzepatide-based drugs have caught up significantly to Novo Nordisk’s semaglutide-based ones. As a result, ...
Novo Nordisk (($NVO)) announced an update on their ongoing clinical study. Study Overview: Novo Nordisk is conducting a study titled ‘Safety, ...
Get the latest on Novo Nordisk's Alzheimer's trial, stock outlook, and market risks. See what investors need to know before ...
2hon MSN
Layoffs are piling up, raising worker anxiety. Here are some companies that have cut jobs recently
The latest job cuts hit Microsoft’s Xbox video game business and other divisions. The company has cited “organizational ...
The overhaul comes after the foundation ousted former chief executive Lars Fruergaard Jørgensen in May, blaming him for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback